3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sarcoma
7
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Lymphoma, Large B-Cell, Diffuse
3
Sarcoma, Clear Cell
2
Rhabdomyosarcoma
2
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neurofibrosarcoma
2
Nerve Sheath Neoplasms
2
Lymphoma
2
Liposarcoma
2
Hodgkin Disease
2
Histiocytoma, Angiomatoid Fibrous
2
Granuloma, Plasma Cell
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Wilms Tumor
1
Vascular Neoplasms
1
Teratoma
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Pleuropulmonary blastoma
1
Perivascular Epithelioid Cell Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms, Adipose Tissue
1
Interventions
Etoposide
3
fludarabine phosphate
2
fludarabine
2
Cyclophosphamide
2
Carboplatin
2
repotrectinib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
Vorinostat
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Ifosfamide
1
Cytapheresis
1
Cisplatin
1
Bleomycin
1
Biopsy
1
Automobiles
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Ifosfamide
×
90 days
×
Clear all
NCT00864318
2026-04-14
TICE
Institut Claudius Regaud
Phase 2
Completed
101 enrolled